Dr. Hoe-yong Lee, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 1945 Morris Ave, Union, NJ 07083 Phone: 908-687-2422 |
News Archive
ACT Biotech Inc., a privately held biotechnology company developing a portfolio of oral kinase inhibitors as anti-cancer drugs, today announced the acceptance of the Investigational New Drug (IND) application for ACTB1003 by the US Food and Drug Administration (FDA). The company has now assembled a complete preclinical package, including manufacturing and toxicology studies, allowing ACTB1003 to enter a clinical trial.
Abraxis BioScience, Inc., a fully integrated biotechnology company, announced that the updated survival findings from a Phase I/II clinical trial evaluating the chemotherapy agent ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in combination with gemcitabine for first-line treatment of patients with metastatic pancreatic cancer will be discussed during a keynote address on April 20 at the 101st Annual Meeting of the American Association for Cancer Research (AACR) being held in Washington, D.C.
A University of Florida engineer has built a working prototype for a small, portable system that can monitor a person's breathing and heart rate automatically via wireless signal, with no need for cords or plugs. The goal is to make it easy for people to check their own vital signs, and then transmit them in real time to medical personnel through a cell phone or Internet connection, all with little more than a press of a button.
Both Asia and Africa are home to many plants that can be used for the treatment of many diseases and their medicinal properties are gaining interest in western societies.
Scientists have made an important step forward in their understanding of cryoprotectants - compounds that act as natural 'antifreeze' to protect drugs, food and tissues stored at sub-zero temperatures.
› Verified 3 days ago